Triferic AVNU Alternatives Compared
| Triferic AVNU (ferric pyrophosphate) | Ferrous sulfate | Aranesp (darbepoetin alfa) |
|
|---|
| Triferic AVNU (ferric pyrophosphate) | Ferrous sulfate | Aranesp (darbepoetin alfa) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Anemia Due to Chronic Kidney Disease. Triferic AVNU may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Ferrous sulfate is an iron supplement that may be used to prevent or treat iron-deficiency anemia. Gastrointestinal side effects are common. Prescribed for Iron Deficiency Anemia, Anemia Due to... View more |
Prescription only
Prescribed for Anemia Due to Chronic Kidney Disease, Anemia - Chemotherapy Induced. Aranesp may also be used for purposes not listed in this medication guide. |
Related suggestions Anemia Due to Chronic Kidney Disease
|
|||||||
| More about Triferic AVNU (ferric pyrophosphate) | More about Ferrous sulfate | More about Aranesp (darbepoetin alfa) | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Ferrous sulfate has an average rating of 5.5 out of 10 from a total of 46 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 36% reported a negative effect. |
Aranesp has an average rating of 9.0 out of 10 from a total of 4 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
Lower cost generic |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Aranesp prices |
||||||||
| Dosage Forms Available | ||||||||||
|
N/A |
|
|
||||||||
| Brand Names | ||||||||||
| Other ferric pyrophosphate brands include: Triferic | Chem-Sol, Fe 50, Fe Caps, Feosol Original, Fer-In-Sol, Feratab, Fero-Gradumet Filmtab, Ferro-Time, Ferrospace, Ferrousal, Iron Sulfate, Slow Fe, Slow Release Iron View more |
N/A |
||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
1.48 hours |
N/A |
49 hours |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 31 drugs are known to interact with Triferic AVNU:
|
A total of 87 drugs are known to interact with Ferrous sulfate:
|
A total of 21 drugs are known to interact with Aranesp:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
N/A |
N/A |
September 17, 2001 |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
|||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.